SEC Form D · filed March 1, 2018
Rubius Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Michael S. Rosenblatt · Cambridge, MADirectorTorben S. Nissen · Cambridge, MAExec · DirectorDavid S. Epstein · Cambridge, MADirectorRoger S. Pomerantz · Cambridge, MADirectorNoubar B. Afeyan · Cambridge, MADirectorRobert S. Langer · Cambridge, MADirectorJoanne Protano · Cambridge, MAExecFrancis B. Cuss · Cambridge, MADirectorCatherine B. Sohn · Cambridge, MADirectorRichard Sapp · San Diego, CADirectorKathleen F. Briscoe · RENO, NVExecTim D. Walsh · RENO, NVExec · DirectorMichael Beaudoin · Newport Beach, CADirectorStephen Socolof · San Diego, CADirectorChristine M. Cvijic · Palo Alto, CADirectorKurt G. Deutsch · New York, NYDirectorChristopher L. Carpenter · Cambridge, MAExecAndrew B. Oh · Cambridge, MAExecPECO Property Group LLC · Park City, UTDirectorCrosby E. Howard · Palm Desert, CADirectorSteve E. Nelson · Palm Desert, CADirectorMark Ranalli · Cambridge, MADirectorPeter Sacco · Cambridge, MADirectorJoseph Patrina · West Simsbury, CTExec · DirectorAllan Bernheimer · Pound Ridge, NYExecChristopher L. Carpenter · Cambridge, MAExecFrancis B. Cuss · Cambridge, MADirectorCatherine B. Sohn · Cambridge, MADirectorAndrew B. Oh · Cambridge, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗